Inovio Pharmaceuticals Inc. Common Stock is a leading biotechnology company that focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines for the treatment and prevention of various infectious diseases and cancers. With a strong pipeline of candidates and a robust platform technology, Inovio is poised to make a significant impact in the field of healthcare.
